Journal article
Confirmation of the activity of the interleukin-2 fusion toxin denileukin diftitox against chemorefractory chronic lymphocytic leukemia, including cases with chromosome 17p deletions and without detectable CD25 expression
SJ Morgan, JF Seymour, HM Prince, DA Westerman, MM Wolf
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2004